COMPOUNDING FINDER
Semaglutide is a GLP-1 receptor agonist prescribed for the management of type 2 diabetes and chronic weight management. Delaware patients who have a documented clinical need — such as an allergy to an inactive ingredient in a brand-name product, a need for a dose strength not available commercially, or a requirement for a non-injectable dosage form — may be eligible to receive compounded semaglutide.
As one of the smallest states in the country, Delaware has a limited number of local compounding pharmacies, making mail-order access from nationally licensed facilities especially important for residents. Compounding Finder helps Delaware patients in Wilmington, Dover, Newark, and beyond connect with verified compounding pharmacies that ship directly to their homes.
Compounded semaglutide is prepared by licensed compounding pharmacies using the same active pharmaceutical ingredient found in FDA-approved Ozempic and Wegovy. Unlike commercially manufactured products, compounded versions can be customized:
Compounded medications are not FDA-approved but are prepared under federal (Section 503A/503B) and state pharmacy board regulations.
Yes. Compounded semaglutide is available to Delaware patients through licensed compounding pharmacies. Delaware follows federal compounding regulations under the Drug Quality and Security Act (DQSA).
Key requirements in Delaware:
The Delaware Board of Pharmacy oversees in-state compounding activities. Delaware's position in the mid-Atlantic pharmaceutical corridor and its business-friendly regulatory environment attract healthcare companies, though residents often benefit most from out-of-state compounding pharmacies that ship nationwide.
Compounded semaglutide in Delaware typically costs between $149 and $399 per month, depending on several factors:
Compounded semaglutide is typically not covered by insurance. Brand-name Ozempic costs approximately $998/month and Wegovy approximately $1,349/month without insurance.
Your prescriber will determine the appropriate form and strength based on your clinical needs.
Compounding Finder connects Delaware patients with verified, licensed U.S. compounding pharmacies. Submit your prescription details and compare options — 100% free, no obligation.
Availability may vary. Compare options now to find the right pharmacy for your prescription.
Yes. Licensed 503A and 503B compounding pharmacies can prepare semaglutide for Delaware patients who have a valid prescription and a documented clinical need.
Yes. Compounded semaglutide is a prescription medication. You must have a valid prescription from a licensed healthcare provider. Avoid any source that offers semaglutide without a prescription.
Compounded semaglutide contains the same active ingredient but is not FDA-approved. It is prepared by licensed compounding pharmacies and may differ in inactive ingredients, dosage form, or concentration.
Typically $149 to $399 per month depending on dose, form, and pharmacy. This is significantly less than brand-name alternatives without insurance.
Yes. Many nationally licensed compounding pharmacies ship to Delaware. Compounding Finder helps you find pharmacies that serve your area.
Injectable, sublingual tablet, troche, and oral capsule forms are available. Your prescriber will recommend the appropriate form based on your clinical needs.
← Back to Compounded Semaglutide Overview | Maryland | Pennsylvania | New Jersey
.png){kind=spacer}
